The Latest Breaking News from Cancer

Paloma Shemirani, 23, died in 2024 after refusing treatment for non-Hodgkin lymphoma

He didn't want to distract his sons while their respective NFL careers began.

Paloma Shemirani, 23, died at Royal Sussex County Hospital on July 24 2024 after refusing treatment for non-Hodgkin lymphoma.

Sanders and his medical team announced his diagnosis in a press conference on Monday.

Three emerging biotech companies — Elicio Therapeutics, Cellectis, and Autolus Therapeutics — are attracting “Strong Buy” analyst ratings in 2025 as major clinical, regulatory, and commercial catalysts position them for standout growth in the cancer treatment market.

Biotechnology firms are increasingly turning to innovative combination therapies to tackle hard-to-treat cancers, with promising results sparking investor interest. AIM ImmunoTech Inc. (NYSE:AIM) is the latest to capture attention, as its stock soars following a promising mid-year update from the DURIPANC Phase 2 study.

Full of jeopardy, trauma and humour, Motherboard is a film made by a lone parent using 20 years of footage of her son – starting as a foetus. They talk about the fights, festivals and cancer diagnosis that went into it

Summer is officially here. While many Europeans have been swapping their computers and desk chairs for beachside sun loungers, the longstanding online debate about sunscreen persists.

Celcuity Inc. (NASDAQ:CELC) stock surged on Monday after the company reported topline results from the PIK3CA wild-type cohort of the Phase 3 VIKTORIA-1 trial, which evaluated gedatolisib plus fulvestrant with and without palbociclib versus fulvestrant.

Fermented stevia may hold intriguing anti-cancer properties

Scientists suggest green tea and red wine might support cancer treatment by enhancing its effectiveness and reducing side effects